GPC1 and familial pancreatic carcinoma: In addition, in 2015, one study reported that GPC1 had nearly 100% sensitivity and specificity in both animal models and clinical patients with pancreatic cancer, being able to accurately detect early pancreatic cancer, indicating that GPC1 has great potential as a tumor marker for early detection of pancreatic cancer [13–15].